|
⚲
|
| Keyboard |
| Thomson Todd S
✚
|
|
|---|---|
| CIK # | 0001225707 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001225707] | |
| 4 | [0001225707] | |
| 5 | [0001225707] |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Actuate Therapeutics Inc ACTU
Common Stock
|
2026-01-05 | Sell | 280,000 | $5.80 | 1,624,000 |
|
Actuate Therapeutics Inc ACTU
Stock Options · derivative
|
2025-05-22 | Grant | 15,000 | $0.00 | |
|
Actuate Therapeutics Inc ACTU
Common Stock
|
2024-08-14 | Conversion | 146,870 | ||
|
Actuate Therapeutics Inc ACTU
Common Stock
|
2024-08-14 | Conversion | 138,889 | ||
|
Actuate Therapeutics Inc ACTU
Common Stock
|
2024-08-14 | Conversion | 726,163 | ||
|
Actuate Therapeutics Inc ACTU
Common Stock
|
2024-08-14 | Conversion | 1,058,318 | ||
|
Actuate Therapeutics Inc ACTU
Common Stock
|
2024-08-14 | Conversion | 69,445 | ||
|
Actuate Therapeutics Inc ACTU
Common Stock
|
2024-08-14 | Conversion | 132,908 | ||
|
Actuate Therapeutics Inc ACTU
Common Stock
|
2024-08-14 | Conversion | 24,138 | ||
|
Actuate Therapeutics Inc ACTU
Common Stock
|
2024-08-14 | Conversion | 49,984 | ||
|
Actuate Therapeutics Inc ACTU
Common Stock
|
2024-08-14 | Option exercise | 28,464 | $5.27 | 150,005 |
|
Actuate Therapeutics Inc ACTU
Common Stock
|
2024-08-14 | Sell | 18,750 | $8.00 | 150,000 |
|
Actuate Therapeutics Inc ACTU
Series B-4 Redeemable Convertible Preferred Stock · derivative
|
2024-08-14 | Conversion | 230,597 | ||
|
Actuate Therapeutics Inc ACTU
Series B-4 Redeemable Convertible Preferred Stock · derivative
|
2024-08-14 | Conversion | 132,908 | ||
|
Actuate Therapeutics Inc ACTU
Series C Redeemable Convertible Preferred Stock · derivative
|
2024-08-14 | Conversion | 49,984 | ||
|
Actuate Therapeutics Inc ACTU
Series C Redeemable Convertible Preferred Stock · derivative
|
2024-08-14 | Conversion | 24,138 | ||
|
Actuate Therapeutics Inc ACTU
Series B-3 Redeemable Convertible Preferred Stock · derivative
|
2024-08-14 | Conversion | 138,889 | ||
|
Actuate Therapeutics Inc ACTU
Series B-3 Redeemable Convertible Preferred Stock · derivative
|
2024-08-14 | Conversion | 146,870 | ||
|
Actuate Therapeutics Inc ACTU
Series B-3 Redeemable Convertible Preferred Stock · derivative
|
2024-08-14 | Conversion | 69,445 | ||
|
Actuate Therapeutics Inc ACTU
Series B-2 Redeemable Convertible Preferred Stock · derivative
|
2024-08-14 | Conversion | 726,163 | ||
| showing 20 of 39 most recent transactions | |||||